Aina Muceniece Virotherapy Foundation

11/05/2026

Scientific progress does not begin with certainty - it begins with curiosity.

The willingness to ask questions, explore new ideas, and look beyond traditional ways of thinking has shaped some of the world’s most important discoveries in medicine and science. Every breakthrough starts with someone choosing to explore what others may have overlooked.

At Aina Muceniece Virotherapy Foundation, we believe curiosity remains one of the most important driving forces behind scientific development, education, and future innovation. By supporting scientific thinking and awareness, we help continue the spirit of exploration that drives progress forward.

23/04/2026

Wishing Smart Nanovirus great success with the launch of its new product - RIGVIR X. 🤩

It’s go time! 🔥 The pre-launch support was absolutely unreal—thank you! 🙌

We are officially packed, stacked, and ready for immediate dispatch. Order today, and it ships out straight away. Don't miss out on the first drop before it's gone.

Secure yours now 🔗 www.smartnanovirus.com

26/03/2026

Great to see RIGVIR X coming together with such strong scientific experience behind it, especially with Prof. Ivars Kalviņš involved.

23/03/2026

On what would have been her 102nd birthday, we remember Professor Aina Muceniece and the path she created through her scientific work.

Her name remains closely connected to Rigvir, but her impact reaches far beyond a single discovery. Through knowledge, persistence, and belief in new possibilities, she left behind a legacy that continues to matter in science and in the lives touched by her work.

Today is a moment to honor her memory and the meaning of what she gave to future generations.

16/03/2026

The scientific work of Professor Aina Muceniece continues to inspire new developments in virus-based biotechnology.

The recently launched RIGVIR X, introduced by Smart Nanovirus, represents a new format built upon the principles of Rigvir technology originally developed through Professor Muceniece’s pioneering research.

By introducing a format designed for broader accessibility, this development reflects the continued evolution of her scientific legacy and the expanding interest in preventive approaches to cancer and longevity.

For the Foundation, such advancements demonstrate how Professor Aija Muceniece’s work continues to influence modern research, innovation, and the search for safer approaches to cancer prevention. We believe she would be happy to see this progress. Thank you to everyone who contributed to the development of Rigvir X.

06/03/2026

The work of the Aina Muceniece Virotherapy Foundation is guided by a clear purpose — to preserve scientific knowledge, support patients, and encourage continued research in oncology.

Inspired by the legacy of Professor Aina Muceniece, the Foundation works to ensure that her contributions to medical science continue to benefit future generations.

Through education, collaboration, and patient support initiatives, we strive to keep this scientific legacy alive and meaningful for people around the world.

18/02/2026

📩 Sign up with your email today to be the first to access RIGVIR X at a special early-bird price.

Smart Nanovirus Biotechnology is introducing RIGVIR X — a new liquid, daily-format supplement powered by Natural Intelligence.

Developed for health-conscious, preventive-minded individuals, RIGVIR X is designed to include a beneficial virus as part of a forward-thinking long-term health strategy.

ℹ️ Important: Rigvir X complements our existing portfolio and does not replace Rigvir SE capsules. Rigvir SE remains a targeted, premium-grade biotechnology developed for individuals with identifiable increased cancer risks or specific needs.

👉 Visit www.smartnanovirus.com to learn more and register today.

14/02/2026

15 years ago, on this day, Aina Muceniece went to the paradise she truly deserved — but her work, ideas, and impact remained with us.

She was the inventor of Rigvir and a pioneer of cancer virotherapy, dedicating her life to science, innovation, and helping patients when conventional paths offered little hope. Her vision and determination opened new directions in oncology and changed the lives of thousands of people around the world.

Today, we remember not only a remarkable scientist, but a person whose legacy continues through research, patients, and the ongoing work inspired by her mission.

Her contribution lives on.
Her legacy endures.

04/02/2026

World Cancer Day is a moment to reflect on the people behind every diagnosis — patients, families, and caregivers whose lives are deeply affected by cancer.

The Aina Muceniece Virotherapy Foundation was established to continue the scientific legacy of Professor Aina Muceniece and to support access to virotherapy, patient rights, education in oncology, and quality of life during treatment.

Today, we stand in solidarity with patients around the world and reaffirm our commitment to compassion, awareness, and the ongoing pursuit of scientific progress in cancer care.

27/01/2026

The Foundation was established to support access to cancer virotherapy and to assist patients and their families during treatment.

It continues the scientific legacy of Professor Aina Muceniece, the founder of cancer virotherapy and inventor of the Rigvir virus.

Our work focuses on patient support, education in oncology, protection of patients’ rights, and the promotion of scientific research in virotherapy.

Founded in 2016 by her family and colleagues.